News Snapshot:
India’s pharmaceutical industry is at a pivotal juncture. With its well-established prowess in generic drug manufacturing, it has been called on by the world to build a reliable base for the manufacture of raw materials, which offers an opportunity for India to attract the bulk of the pharmaceutical supply chains away from China. India has answered this call and is well-poised to tap into its potential, gather its best in the mission and meet this geopolitical demand. In recent years, India has been actively promoting the growth of domestic manufacturing in active pharmaceutical ingredients (APIs), and this policy is already...